Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 18,844 | 6,927 | 2,376 | 0 | 0 |
| Cost of Goods | 11,875 | 7,267 | 4,263 | N/A | N/A |
| Gross Profit | 6,969 | -340 | -1,887 | N/A | N/A |
| Operating Expenses | 86,717 | 120,568 | 42,130 | 18,789 | 26,867 |
| Operating Income | -78,873 | -120,641 | -43,754 | -18,789 | -26,867 |
| Interest Expense | 11,552 | 6,284 | 3,024 | 2,189 | 869 |
| Other Income | -2,540 | -1,023 | 19,053 | 478 | -163 |
| Pre-tax Income | -92,965 | -127,948 | -27,725 | -20,500 | -27,899 |
| Income Tax | -5,171 | -14,683 | -660 | N/A | N/A |
| Net Income Continuous | -87,794 | -113,265 | -27,065 | -20,500 | -27,899 |
| Minority Interests | N/A | N/A | N/A | -3,489 | N/A |
| Net Income | $-87,794 | $-113,265 | $-27,065 | $-17,011 | $-27,899 |
| EPS Basic Total Ops | -2.26 | -12.56 | -21.16 | -40.65 | -68.01 |
| EPS Basic Continuous Ops | -2.26 | -12.56 | -21.16 | -48.98 | -68.01 |
| EPS Diluted Total Ops | -2.26 | -12.56 | -21.16 | -40.65 | -68.01 |
| EPS Diluted Continuous Ops | -2.26 | -12.56 | -21.16 | -48.98 | -68.01 |
| EBITDA(a) | $-70,595 | $-44,113 | $-40,781 | $-17,944 | $-26,479 |